Key Details
Price
$10.77PE Ratio
5.64Annual ROE
19.56%Beta
-Events Calendar
Next earnings date:
May 7, 2025Recent quarterly earnings:
Feb 27, 2025Recent annual earnings:
Feb 27, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 25, 25 HC Wainwright & Co.
BuyFeb 4, 25 HC Wainwright & Co.
BuyDec 5, 24 Roth MKM
BuyNov 6, 24 Oppenheimer
OutperformNov 6, 24 HC Wainwright & Co.
BuyAug 26, 24 Oppenheimer
OutperformAug 14, 24 HC Wainwright & Co.
BuyJun 25, 24 HC Wainwright & Co.
BuyMar 18, 24 HC Wainwright & Co.
BuyJan 5, 24 Oppenheimer
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Entrada Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Entrada Therapeutics?
- Does Entrada Therapeutics pay dividends?
- What sector is Entrada Therapeutics in?
- What industry is Entrada Therapeutics in?
- What country is Entrada Therapeutics based in?
- When did Entrada Therapeutics go public?
- Is Entrada Therapeutics in the S&P 500?
- Is Entrada Therapeutics in the NASDAQ 100?
- Is Entrada Therapeutics in the Dow Jones?
- When was Entrada Therapeutics's last earnings report?
- When does Entrada Therapeutics report earnings?
- Should I buy Entrada Therapeutics stock now?
What is the ticker symbol for Entrada Therapeutics?
The ticker symbol for Entrada Therapeutics is NASDAQ:TRDA
Does Entrada Therapeutics pay dividends?
No, Entrada Therapeutics does not pay dividends
What sector is Entrada Therapeutics in?
Entrada Therapeutics is in the Healthcare sector
What industry is Entrada Therapeutics in?
Entrada Therapeutics is in the Biotechnology industry
What country is Entrada Therapeutics based in?
Entrada Therapeutics is headquartered in United States
When did Entrada Therapeutics go public?
Entrada Therapeutics's initial public offering (IPO) was on October 29, 2021
Is Entrada Therapeutics in the S&P 500?
No, Entrada Therapeutics is not included in the S&P 500 index
Is Entrada Therapeutics in the NASDAQ 100?
No, Entrada Therapeutics is not included in the NASDAQ 100 index
Is Entrada Therapeutics in the Dow Jones?
No, Entrada Therapeutics is not included in the Dow Jones index
When was Entrada Therapeutics's last earnings report?
Entrada Therapeutics's most recent earnings report was on Feb 27, 2025
When does Entrada Therapeutics report earnings?
The next expected earnings date for Entrada Therapeutics is May 7, 2025
Should I buy Entrada Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions